Zhang Xiaoqiu - 30 Dec 2024 Form 3 Insider Report for Park Ha Biological Technology Co., Ltd. (BYAH)

Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
3
Accepted by SEC
07 Apr 2026, 08:24:16 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Zhang Xiaoqiu

Key filing fact

Zhang Xiaoqiu filed Form 3 for Park Ha Biological Technology Co., Ltd. (BYAH) on 07 Apr 2026.

Key facts

  • This page summarizes Zhang Xiaoqiu's Form 3 filing for Park Ha Biological Technology Co., Ltd. (BYAH).
  • 0 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 07 Apr 2026, 08:24.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002053293 Primary reporting owner

Zhang Xiaoqiu

Relationship
CEO, Director, 10%+ Owner
Address
PLOT C, NO.1 LIHU, BINHU DISTRICT, WUXI, CHINA
Signature
/s/ Zhang Xiaoqiu
Signature date
07 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BYAH holding

Class B Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
381,000
Date
30 Dec 2024
Ownership
By Xiaoqiu Holding Ltd
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Directly held by Xiaoqiu Holdings Limited. Ms. Zhang is the sole shareholder and director of Xiaoqiu Holdings Limited. The Reporting Person acquired 381,000 Class B Ordinary Shares on October 11, 2022.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .